BAL Pharma maintains its strong growth momentum; reports PAT growth of 23% YoY for 9MFY22
PLI Scheme is shot in the arm for company’s Future growth BENGALURU, India, Feb. 11, 2022 /PRNewswire/ — BAL Pharma, a
Read MorePLI Scheme is shot in the arm for company’s Future growth BENGALURU, India, Feb. 11, 2022 /PRNewswire/ — BAL Pharma, a
Read MoreIn its Q4 2021 evaluation, RevBits Endpoint Security moves closer to 100% Detection by Achieving a 99.8% Capability. MINEOLA, N.Y.,
Read More– Character of the world’s largest consumer fair for the industry to be preserved – Dominique Metzler to continue as
Read More